Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
European Journal of Immunology|December 18, 2009
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cellsThomas J Scriba, Michele Tameris, Nazma Mansoor, et al.
Vaccine|June 15, 2015
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic settingAdam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by MycobacteriaSara Suliman, Melissa Murphy, Munyaradzi Musvosvi, et al.
Tuberculosis (Edinburgh, Scotland)|December 6, 2018
Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meetingYuri F van der Heijden, Fareed Abdullah, Bruno B Andrade, et al.
The Journal of Infectious Diseases|May 6, 2024
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in BrazilSimon C Mendelsohn, Bruno B Andrade, Stanley Kimbung Mbandi, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2025
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosisHumphrey Mulenga, Justin Shenje, Simon C Mendelsohn, et al.
Frontiers in Immunology|March 15, 2021
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young AdultsRichard Baguma, Stanley Kimbung Mbandi, Miguel J Rodo, et al.
Nature Medicine|January 5, 2023
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infectionMunyaradzi Musvosvi, Huang Huang, Chunlin Wang, et al.
Communications Biology|October 10, 2020
Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccinesVirginie Rozot, Elisa Nemes, Hennie Geldenhuys, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
European Journal of Immunology|December 18, 2009
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cellsThomas J Scriba, Michele Tameris, Nazma Mansoor, et al.
Vaccine|June 15, 2015
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic settingAdam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by MycobacteriaSara Suliman, Melissa Murphy, Munyaradzi Musvosvi, et al.
Tuberculosis (Edinburgh, Scotland)|December 6, 2018
Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meetingYuri F van der Heijden, Fareed Abdullah, Bruno B Andrade, et al.
The Journal of Infectious Diseases|May 6, 2024
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in BrazilSimon C Mendelsohn, Bruno B Andrade, Stanley Kimbung Mbandi, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2025
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosisHumphrey Mulenga, Justin Shenje, Simon C Mendelsohn, et al.
Frontiers in Immunology|March 15, 2021
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young AdultsRichard Baguma, Stanley Kimbung Mbandi, Miguel J Rodo, et al.
Nature Medicine|January 5, 2023
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infectionMunyaradzi Musvosvi, Huang Huang, Chunlin Wang, et al.
Communications Biology|October 10, 2020
Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccinesVirginie Rozot, Elisa Nemes, Hennie Geldenhuys, et al.
Pageof 23